Trial Identifier: | D9603C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05454787 |
Start Date: | June 2022 |
Primary Completion Date: | May 2025 |
Study Completion Date: | May 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan | Aichi, Japan |
Japan | Akita, Japan |
Japan | Aomori, Japan |
Japan | Chiba, Japan |
Japan | Ehime, Japan |
Japan | Fukui, Japan |
Japan | Fukuoka, Japan |
Japan | Fukushima, Japan |
Japan | Gifu, Japan |
Japan | Gunma, Japan |
Japan | Hiroshima, Japan |
Japan | Hokkaido, Japan |
Japan | Hyogo, Japan |
Japan | Ibaraki, Japan |
Japan | Ishikawa, Japan |
Japan | Iwate, Japan |
Japan | Kagawa, Japan |
Japan | Kagoshima, Japan |
Japan | Kanagawa, Japan |
Japan | Kochi, Japan |
Japan | Kumamoto, Japan |
Japan | Kyoto, Japan |
Japan | Mie, Japan |
Japan | Miyagi, Japan |
Japan | Miyazaki, Japan |
Japan | Nagano, Japan |
Japan | Nagasaki, Japan |
Japan | Nara, Japan |
Japan | Niigata, Japan |
Japan | Okayama, Japan |
Japan | Okinawa, Japan |
Japan | Osaka, Japan |
Japan | Saga, Japan |
Japan | Saitama, Japan |
Japan | Shiga, Japan |
Japan | Shimane, Japan |
Japan | Shizuoka, Japan |
Japan | Tochigi, Japan |
Japan | Tokushima, Japan |
Japan | Tokyo, Japan |
Japan | Tottori, Japan |
Japan | Toyama, Japan |
Japan | Wakayama, Japan |
Japan | Yamagata, Japan |
Japan | Yamaguchi, Japan |
Japan | Yamanashi, Japan |